| 英文别名 |
ABBV-075;Mivebresib (ABBV-075);ABBV075;Mivebresib;VR86R11J7J;N-[4-(2,4-Difluorophenoxy)-3-(6-Methyl-7-Oxo-6,7-Dihydro-1h-Pyrrolo[2,3-C]pyridin-4-Yl)phenyl]ethanesulfonamide;N-(4-(2,4-difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide;Ethanesulfonamide, N-[4-(2,4-difluorophenoxy)-3-(6,7-dihydro-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl]-;Mivebresib [INN];Ethanesulfonamide, N-(4-(2,4-difluorophenoxy)-3-(6,7-dihydro-6-methyl-7-oxo-1H-pyrro;MIVEBRESIB [WHO-DD];DA-65490;CCG-269326;AKOS030628486;MFCD30377200;Ethanesulfonamide, N-(4-(2,4-difluorophenoxy)-3-(6,7-dihydro-6-methyl-7-oxo-1H-pyrrolo(2,3-C)pyridin-4-yl)phenyl)-;Mivebresib [USAN:INN];ABBV 075;Mivebresib [USAN];Q27291978;Mivebresib (USAN/INN);GTPL9117;SY347011;N-[4-(2,4-difluorophenoxy)-3-{6-methyl-7-oxo-1H,6H,7H-pyrrolo[2,3-c]pyridin-4-yl}phenyl]ethane-1-sulfonamide;Example 36 [WO2013097601];US9296741, 36;NSC793103;D11479;8NG;AS-75006;ABBV-075 (Mivebresib);BCP18592;s8400;N-[4-(2,4-difluorophenoxy)-3-(6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl]ethanesulfonamide;Mivebresib(ABBV-075;SB19768;RDONXGFGWSSFMY-UHFFFAOYSA-N;BA166577;Mivebresib(ABBV-075?;CHEMBL3987016;SCHEMBL15068241;UNII-VR86R11J7J;CS-5815;HY-100015;Mivebresib; ABBV-075;1445993-26-9;BDBM220447;GLXC-10559;EX-A1082;N-(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro- 1H-pyrrolo(2,3-C)pyridin-4-yl)phenyl)ethanesulfonamide;NSC-793103;AC-29897 |
